{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:20:03Z","timestamp":1775611203962,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science and Technology Program of Jiangxi Traditional Chinese Medicine","award":["2022B829"],"award-info":[{"award-number":["2022B829"]}]},{"name":"the Science and Technology Project of Jiangxi Provincial Department of Education","award":["GJJ2001448"],"award-info":[{"award-number":["GJJ2001448"]}]},{"name":"the Science and Technology Plan of Jiangxi Provincial Health Commission","award":["202210345"],"award-info":[{"award-number":["202210345"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99639-9","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:15:33Z","timestamp":1746184533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genomic and phenotypic adaptations of methicillin resistant Staphylococcus aureus during vancomycin therapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Yiyue","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YunXue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian-Bin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"issue":"4","key":"99639_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","volume":"17","author":"NA Turner","year":"2019","unstructured":"Turner, N. A. et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat. Rev. Microbiol. 17 (4), 203\u2013218. https:\/\/doi.org\/10.1038\/s41579-018-0147-4 (2019).","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"99639_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13054-017-1801-3","volume":"21","author":"A Hassoun","year":"2017","unstructured":"Hassoun, A., Linden, P. K. & Friedman, B. Incidence, prevalence, and management of MRSA bacteremia across patient populations\u2014A review of recent developments in MRSA management and treatment. Crit. Care  21 (1), 211. https:\/\/doi.org\/10.1186\/s13054-017-1801-3 (2017).","journal-title":"Crit. Care"},{"issue":"3","key":"99639_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijpam.2017.07.001","volume":"4","author":"O Alzomor","year":"2017","unstructured":"Alzomor, O., Alfawaz, T. & Alshahrani, D. Invasive community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection in children: case series and literature review. Int. J. Pediatr. Adolesc. Med. 4 (3), 119\u2013123. https:\/\/doi.org\/10.1016\/j.ijpam.2017.07.001 (2017).","journal-title":"Int. J. Pediatr. Adolesc. Med."},{"issue":"1","key":"99639_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/JCM.01128-10","volume":"49","author":"SW Satola","year":"2011","unstructured":"Satola, S. W., Farley, M. M., Anderson, K. F. & Patel, J. B. Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J. Clin. Microbiol. 49 (1), 177\u2013183. https:\/\/doi.org\/10.1128\/JCM.01128-10 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"99639_CR5","doi-asserted-by":"publisher","unstructured":"Ca, M., Bj, W., Dj, S. S. & Sm, S. Rapid detection of vancomycin-intermediate Staphylococcus aureus by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 54 (4). https:\/\/doi.org\/10.1128\/JCM.02428-15 (2016).","DOI":"10.1128\/JCM.02428-15"},{"issue":"1","key":"99639_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3855\/jidc.12799","volume":"15","author":"D Gazel","year":"2021","unstructured":"Gazel, D., Erinmez, M., B\u00fcy\u00fckta\u015f Manay, A. & Zer, Y. Investigation of heteroresistant vancomycin intermediate Staphylococcus aureus among MRSA isolates. J. Infect. Dev. Ctries. 15 (1), 89\u201394. https:\/\/doi.org\/10.3855\/jidc.12799 (2021).","journal-title":"J. Infect. Dev. Ctries."},{"issue":"3","key":"99639_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40121-015-0077-7","volume":"4","author":"JR Smith","year":"2015","unstructured":"Smith, J. R., Roberts, K. D., Rybak, M. J. & Dalbavancin A novel lipoglycopeptide antibiotic with extended activity against gram-positive infections. Infect. Dis. Ther. 4 (3), 245\u2013258. https:\/\/doi.org\/10.1007\/s40121-015-0077-7 (2015).","journal-title":"Infect. Dis. Ther."},{"issue":"8","key":"99639_CR8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1021\/acsinfecdis.2c00253","volume":"8","author":"E van Groesen","year":"2022","unstructured":"van Groesen, E., Innocenti, P. & Martin, N. I. Recent advances in the development of semisynthetic glycopeptide antibiotics: 2014\u20132022. ACS Infect. Dis. 8 (8), 1381\u20131407. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00253 (2022).","journal-title":"ACS Infect. Dis."},{"issue":"6","key":"99639_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ijantimicag.2016.04.009","volume":"47","author":"MD Huband","year":"2016","unstructured":"Huband, M. D. et al. In vitro activity of Dalbavancin against multidrug-resistant Staphylococcus aureus and Streptococci from patients with documented infections in Europe and surrounding regions (2011\u20132013). Int. J. Antimicrob. Agents  47 (6), 495\u2013499. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.04.009 (2016).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"99639_CR10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2147\/TCRM.S86330","volume":"12","author":"KD Leuthner","year":"2016","unstructured":"Leuthner, K. D., Buechler, K. A., Kogan, D., Saguros, A. & Lee, H. S. Clinical efficacy of Dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Ther. Clin. Risk Manag.  12, 931\u2013940. https:\/\/doi.org\/10.2147\/TCRM.S86330 (2016).","journal-title":"Ther. Clin. Risk Manag"},{"issue":"5","key":"99639_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/cid\/civ982","volume":"62","author":"MW Dunne","year":"2016","unstructured":"Dunne, M. W. et al. A randomized clinical trial of single-dose versus weekly Dalbavancin for treatment of acute bacterial skin and skin structure infection. Clin. Infect. Dis. 62 (5), 545\u2013551. https:\/\/doi.org\/10.1093\/cid\/civ982 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"99639_CR12","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing, 33th Edn. Wayne, PA: Clinical and Laboratory Standards Institute. (2023)."},{"issue":"4","key":"99639_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jac\/47.4.399","volume":"47","author":"M Wootton","year":"2001","unstructured":"Wootton, M. et al. A modified population analysis profile (PAP) method to detect hetero-resistance to Vancomycin in Staphylococcus aureus in a UK hospital. J. Antimicrob. Chemother. 47 (4), 399\u2013403. https:\/\/doi.org\/10.1093\/jac\/47.4.399 (2001).","journal-title":"J. Antimicrob. Chemother."},{"issue":"17","key":"99639_CR14","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34 (17), i884\u2013i890. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560 (2018).","journal-title":"Bioinformatics"},{"issue":"6","key":"99639_CR15","doi-asserted-by":"publisher","first-page":"e1005595","DOI":"10.1371\/journal.pcbi.1005595","volume":"13","author":"RR Wick","year":"2017","unstructured":"Wick, R. R., Judd, L. M., Gorrie, C. L., Holt, K. E. & Unicycler Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput. Biol. 13 (6), e1005595. https:\/\/doi.org\/10.1371\/journal.pcbi.1005595 (2017).","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"99639_CR16","doi-asserted-by":"publisher","first-page":"e00612","DOI":"10.1128\/mSphere.00612-17","volume":"3","author":"H Kaya","year":"2018","unstructured":"Kaya, H. et al. SCCmecFinder, a web-based tool for typing of Staphylococcal cassette chromosome mec in Staphylococcus aureus using whole-genome sequence data. mSphere 3 (1), e00612\u2013e00617. https:\/\/doi.org\/10.1128\/mSphere.00612-17 (2018).","journal-title":"mSphere"},{"issue":"D1","key":"99639_CR17","doi-asserted-by":"publisher","first-page":"D687","DOI":"10.1093\/nar\/gky1080","volume":"47","author":"B Liu","year":"2019","unstructured":"Liu, B., Zheng, D., Jin, Q., Chen, L. & Yang, J. VFDB 2019: a comparative pathogenomic platform with an interactive web interface. Nucleic Acids Res. 47 (D1), D687\u2013D692. https:\/\/doi.org\/10.1093\/nar\/gky1080 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"99639_CR18","doi-asserted-by":"publisher","first-page":"D517","DOI":"10.1093\/nar\/gkz935","volume":"48","author":"BP Alcock","year":"2020","unstructured":"Alcock, B. P. et al. CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res. 48 (D1), D517\u2013D525. https:\/\/doi.org\/10.1093\/nar\/gkz935 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"99639_CR19","doi-asserted-by":"publisher","first-page":"17696","DOI":"10.1038\/s41598-018-35793-7","volume":"8","author":"M Feldman","year":"2018","unstructured":"Feldman, M., Smoum, R., Mechoulam, R. & Steinberg, D. Antimicrobial potential of endocannabinoid and endocannabinoid-like compounds against methicillin-resistant Staphylococcus aureus. Sci. Rep. 8 (1), 17696. https:\/\/doi.org\/10.1038\/s41598-018-35793-7 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"99639_CR20","doi-asserted-by":"publisher","first-page":"2165969","DOI":"10.1080\/22221751.2023.2165969","volume":"12","author":"Y Xiao","year":"2023","unstructured":"Xiao, Y. et al. Phylogenetic analysis and virulence characteristics of methicillin-resistant Staphylococcus aureus ST764-SCCmec II: an emerging hypervirulent clone ST764-t1084 in China. Emerg. Microbes Infect. 12 (1), 2165969. https:\/\/doi.org\/10.1080\/22221751.2023.2165969 (2023).","journal-title":"Emerg. Microbes Infect."},{"issue":"4","key":"99639_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (4), 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"issue":"8","key":"99639_CR22","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1128\/AAC.01563-10","volume":"55","author":"M Shoji","year":"2011","unstructured":"Shoji, M. et al. WalK and ClpP mutations confer reduced Vancomycin susceptibility in Staphylococcus aureus. Antimicrob. Agents Chemother. 55 (8), 3870\u20133881. https:\/\/doi.org\/10.1128\/AAC.01563-10 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"99639_CR23","doi-asserted-by":"publisher","first-page":"151473","DOI":"10.1016\/j.ijmm.2021.151473","volume":"311","author":"J Zhu","year":"2021","unstructured":"Zhu, J., Liu, B., Shu, X. & Sun, B. A novel mutation of walk confers vancomycin-intermediate resistance in methicillin-susceptible Staphylococcus aureus. Int. J. Med. Microbiol. 311 (2), 151473. https:\/\/doi.org\/10.1016\/j.ijmm.2021.151473 (2021).","journal-title":"Int. J. Med. Microbiol."},{"issue":"12","key":"99639_CR24","doi-asserted-by":"publisher","first-page":"a026989","DOI":"10.1101\/cshperspect.a026989","volume":"6","author":"D Zeng","year":"2016","unstructured":"Zeng, D. et al. Approved glycopeptide antibacterial drugs: mechanism of action and resistance. Cold Spring Harb Perspect. Med. 6 (12), a026989. https:\/\/doi.org\/10.1101\/cshperspect.a026989 (2016).","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"1","key":"99639_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40121-014-0023-0","volume":"3","author":"KE Barber","year":"2014","unstructured":"Barber, K. E., Ireland, C. E., Bukavyn, N. & Rybak, M. J. Observation of Seesaw effect with Vancomycin, Teicoplanin, daptomycin and Ceftaroline in 150 unique MRSA strains. Infect. Dis. Ther. 3 (1), 35\u201343. https:\/\/doi.org\/10.1007\/s40121-014-0023-0 (2014).","journal-title":"Infect. Dis. Ther."},{"issue":"2","key":"99639_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/cid\/cir340","volume":"53","author":"A Dhand","year":"2011","unstructured":"Dhand, A. et al. Use of antistaphylococcal \u03b2-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin. Infect. Dis. 53 (2), 158\u2013163. https:\/\/doi.org\/10.1093\/cid\/cir340 (2011).","journal-title":"Clin. Infect. Dis."},{"issue":"22","key":"99639_CR27","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1073\/pnas.0609839104","volume":"104","author":"MM Mwangi","year":"2007","unstructured":"Mwangi, M. M. et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. U S A. 104 (22), 9451\u20139456. https:\/\/doi.org\/10.1073\/pnas.0609839104 (2007).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"99639_CR28","doi-asserted-by":"publisher","first-page":"1387855","DOI":"10.3389\/fmicb.2024.1387855","volume":"15","author":"L Huang","year":"2024","unstructured":"Huang, L. et al. Genomic characterization and outbreak investigations of methicillin-resistant Staphylococcus aureus in a county-level hospital in China. Front. Microbiol. 15, 1387855. https:\/\/doi.org\/10.3389\/fmicb.2024.1387855 (2024).","journal-title":"Front. Microbiol."},{"issue":"1","key":"99639_CR29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1080\/22221751.2022.2032373","volume":"11","author":"B Wang","year":"2022","unstructured":"Wang, B. et al. Methicillin-resistant Staphylococcus aureus in China: a multicentre longitudinal study and whole-genome sequencing. Emerg. Microbes Infect. 11 (1), 532\u2013542. https:\/\/doi.org\/10.1080\/22221751.2022.2032373 (2022).","journal-title":"Emerg. Microbes Infect."},{"issue":"suppl_2","key":"99639_CR30","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1093\/cid\/ciy644","volume":"67","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. Using core-genome multilocus sequence typing to monitor the changing epidemiology of methicillin-resistant Staphylococcus aureus in a teaching hospital. Clin. Infect. Dis. 67 (suppl_2), S241\u2013S248. https:\/\/doi.org\/10.1093\/cid\/ciy644 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"99639_CR31","doi-asserted-by":"publisher","unstructured":"Wang, X. et al. Molecular characteristics of community-associated Staphylococcus aureus isolates from pediatric patients with bloodstream infections between 2012 and 2017 in Shanghai, China. Front. Microbiol. 9 https:\/\/doi.org\/10.3389\/fmicb.2018.01211 (2018).","DOI":"10.3389\/fmicb.2018.01211"},{"issue":"4","key":"99639_CR32","doi-asserted-by":"publisher","first-page":"e1004870","DOI":"10.1371\/journal.ppat.1004870","volume":"11","author":"L Tuchscherr","year":"2015","unstructured":"Tuchscherr, L. et al. Sigma factor SigB is crucial to mediate Staphylococcus aureus adaptation during chronic infections. PLoS Pathog. 11 (4), e1004870. https:\/\/doi.org\/10.1371\/journal.ppat.1004870 (2015).","journal-title":"PLoS Pathog"},{"issue":"7","key":"99639_CR33","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1128\/AAC.00160-15","volume":"59","author":"R Gaupp","year":"2015","unstructured":"Gaupp, R. et al. Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype. Antimicrob. Agents Chemother. 59 (7), 4226\u20134238. https:\/\/doi.org\/10.1128\/AAC.00160-15 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"99639_CR34","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1128\/JB.186.4.1175-1181.2004","volume":"186","author":"S Dubrac","year":"2004","unstructured":"Dubrac, S. & Msadek, T. Identification of genes controlled by the essential YycG\/YycF two-component system of Staphylococcus aureus. J. Bacteriol. 186 (4), 1175\u20131181. https:\/\/doi.org\/10.1128\/JB.186.4.1175-1181.2004 (2004).","journal-title":"J. Bacteriol."},{"issue":"22","key":"99639_CR35","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.1128\/JB.00645-07","volume":"189","author":"S Dubrac","year":"2007","unstructured":"Dubrac, S., Boneca, I. G., Poupel, O. & Msadek, T. New insights into the WalK\/WalR (YycG\/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J. Bacteriol. 189 (22), 8257\u20138269. https:\/\/doi.org\/10.1128\/JB.00645-07 (2007).","journal-title":"J. Bacteriol."},{"issue":"4","key":"99639_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ijmm.2007.02.002","volume":"297","author":"A Jansen","year":"2007","unstructured":"Jansen, A. et al. Role of insertion elements and YycFG in the development of decreased susceptibility to Vancomycin in Staphylococcus aureus. Int. J. Med. Microbiol. 297 (4), 205\u2013215. https:\/\/doi.org\/10.1016\/j.ijmm.2007.02.002 (2007).","journal-title":"Int. J. Med. Microbiol."},{"issue":"6","key":"99639_CR37","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1128\/AAC.00039-06","volume":"50","author":"L Friedman","year":"2006","unstructured":"Friedman, L., Alder, J. D. & Silverman, J. A. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob. Agents Chemother. 50 (6), 2137\u20132145. https:\/\/doi.org\/10.1128\/AAC.00039-06 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"99639_CR38","doi-asserted-by":"publisher","first-page":"e1002359","DOI":"10.1371\/journal.ppat.1002359","volume":"7","author":"BP Howden","year":"2011","unstructured":"Howden, B. P. et al. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator walkr. PLoS Pathog. 7 (11), e1002359. https:\/\/doi.org\/10.1371\/journal.ppat.1002359 (2011).","journal-title":"PLoS Pathog"},{"issue":"1","key":"99639_CR39","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1038\/s41467-019-10932-4","volume":"10","author":"IR Monk","year":"2019","unstructured":"Monk, I. R. et al. Zinc-binding to the cytoplasmic PAS domain regulates the essential walk histidine kinase of Staphylococcus aureus. Nat. Commun. 10 (1), 3067. https:\/\/doi.org\/10.1038\/s41467-019-10932-4 (2019).","journal-title":"Nat. Commun."},{"issue":"9","key":"99639_CR40","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/cid\/ciac341","volume":"75","author":"R Zhang","year":"2022","unstructured":"Zhang, R. et al. Emergence of Dalbavancin, Vancomycin, and daptomycin nonsusceptible Staphylococcus aureus in a patient treated with Dalbavancin: case report and isolate characterization. Clin. Infect. Dis. 75 (9), 1641\u20131644. https:\/\/doi.org\/10.1093\/cid\/ciac341 (2022).","journal-title":"Clin. Infect. Dis."},{"issue":"0","key":"99639_CR41","doi-asserted-by":"publisher","first-page":"e00418","DOI":"10.1128\/jb.00418-23","volume":"0","author":"L Ali","year":"2024","unstructured":"Ali, L. & Abdel Aziz, M. H. Crosstalk involving two-component systems in Staphylococcus aureus signaling networks. J. Bacteriol. 0 (0), e00418\u2013e00423. https:\/\/doi.org\/10.1128\/jb.00418-23 (2024).","journal-title":"J. Bacteriol."},{"issue":"2","key":"99639_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1574-6968.2006.00384.x","volume":"262","author":"S Boyle-Vavra","year":"2006","unstructured":"Boyle-Vavra, S., Yin, S. & Daum, R. S. The VraS\/VraR two-component regulatory system required for Oxacillin resistance in community-acquired methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 262 (2), 163\u2013171. https:\/\/doi.org\/10.1111\/j.1574-6968.2006.00384.x (2006).","journal-title":"FEMS Microbiol. Lett."},{"issue":"10","key":"99639_CR43","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1128\/AAC.00356-06","volume":"50","author":"S Gardete","year":"2006","unstructured":"Gardete, S., Wu, S. W., Gill, S. & Tomasz, A. Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob. Agents Chemother. 50 (10), 3424\u20133434. https:\/\/doi.org\/10.1128\/AAC.00356-06 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"99639_CR44","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1128\/AAC.00420-16","volume":"60","author":"Y Katayama","year":"2016","unstructured":"Katayama, Y., Sekine, M., Hishinuma, T., Aiba, Y. & Hiramatsu, K. Complete reconstitution of the vancomycin-intermediate Staphylococcus aureus phenotype of strain Mu50 in vancomycin-susceptible S. aureus. Antimicrob. Agents Chemother. 60 (6), 3730\u20133742. https:\/\/doi.org\/10.1128\/AAC.00420-16 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"99639_CR45","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1093\/jac\/dku297","volume":"69","author":"A Berscheid","year":"2014","unstructured":"Berscheid, A. et al. Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS. J. Antimicrob. Chemother. 69 (12), 3190\u20133198. https:\/\/doi.org\/10.1093\/jac\/dku297 (2014).","journal-title":"J. Antimicrob. Chemother."},{"issue":"8\u20139","key":"99639_CR46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.micinf.2019.04.003","volume":"21","author":"C Gao","year":"2019","unstructured":"Gao, C. et al. VraSR has an important role in immune evasion of Staphylococcus aureus with low level vancomycin resistance. Microbes Infect. 21 (8\u20139), 361\u2013367. https:\/\/doi.org\/10.1016\/j.micinf.2019.04.003 (2019).","journal-title":"Microbes Infect."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99639-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:15:36Z","timestamp":1746184536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99639-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99639"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99639-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"1 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Nanchang University (Jiangxi, China). All methods were performed in accordance with the relevant guidelines and regulations, including the Declaration of Helsinki. Informed consent was obtained from the patient prior to their inclusion in the study. All patient data were anonymized to protect participant privacy, and no identifying information was included in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"15346"}}